Page last updated: 2024-10-31

molsidomine and Pulmonary Fibrosis

molsidomine has been researched along with Pulmonary Fibrosis in 1 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kilic, T1
Parlakpinar, H1
Polat, A1
Taslidere, E1
Vardi, N1
Sarihan, E1
Ermis, H1
Tanbag, K1

Other Studies

1 other study available for molsidomine and Pulmonary Fibrosis

ArticleYear
Protective and therapeutic effect of molsidomine on bleomycin-induced lung fibrosis in rats.
    Inflammation, 2014, Volume: 37, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Bleomycin; Bronchoalveolar Lavage; Catalase; Fem

2014